Sheryl Tan on Due Diligence

September 19, 2024

Investment decisions in deep tech aren't just about evaluating technology – they're about understanding the complete picture. Take Kitea Health, for example. Their work in hydrocephalus monitoring isn't just innovative; it's addressing a critical need for patients and their support networks.

What makes a compelling investment case? It's the combination of three critical elements:

  1. Solving a real, significant problem that people will pay to fix
  2. Having sound science backed by capable development teams
  3. Building a clear path to market with strong commercial potential

But as Sheryl Tan explains in this video, perhaps most importantly, it's about people.

The strongest technical solution won't succeed without the right team to drive it forward. That's why our team looks beyond the technology to assess whether we can work effectively with founders and their teams to build something truly impactful.